Proton pump inhibitors and risk of fractures: A meta-analysis of 11 international studies

American Journal of Medicine

Volumn 124, Issue 6, 2011, Pages 519-526

  Yu, Elaine W ^a   Bauer, Scott R ^b   Bain, Paul A ^c   Bauer, Douglas C ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone mineral density; Calcium absorption; Fracture; H2 receptor antagonists; Osteoporosis; Proton pump inhibitor

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ARTICLE; COMORBIDITY; FRACTURE; HIP FRACTURE; HUMAN; META ANALYSIS (TOPIC); PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SPINE FRACTURE; TREATMENT DURATION;

AGED; ANTI-ULCER AGENTS; BONE DENSITY; CANADA; EUROPE; FEMALE; GASTROINTESTINAL AGENTS; HIP FRACTURES; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; OSTEOPOROTIC FRACTURES; PROTON PUMP INHIBITORS; RESEARCH DESIGN; RISK FACTORS; SPINAL FRACTURES; UNITED STATES;

EID: 79957520670     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.01.007     Document Type: Article

References (45)

1. Top-line Industry Data: 2009 U.S. Sales and Prescription Information. IMS Health Incorporated http://www.imshealth.com Accessed July 5, 2010
2. M. Miyamoto, K. Haruma, M. Kuwabara, M. Nagano, T. Okamoto, and M. Tanaka Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine J Gastroenterol Hepatol 22 2007 639 644 (Pubitemid 46608387)
3. A. Linsky, K. Gupta, E.V. Lawler, J.R. Fonda, and J.A. Hermos Proton pump inhibitors and risk for recurrent Clostridium difficile infection Arch Intern Med 170 2010 772 778
4. M. Sarkar, S. Hennessy, and Y.X. Yang Proton-pump inhibitor use and the risk for community-acquired pneumonia Ann Intern Med 149 2008 391 398
5. S.J. Herzig, M.D. Howell, L.H. Ngo, and E.R. Marcantonio Acid-suppressive medication use and the risk for hospital-acquired pneumonia JAMA 301 2009 2120 2128
6. L. Laine, D. Ahnen, C. McClain, E. Solcia, and J.H. Walsh Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors Aliment Pharmacol Ther 14 2000 651 668 (Pubitemid 30352732)
7. T. Ali, D.N. Roberts, and W.M. Tierney Long-term safety concerns with proton pump inhibitors Am J Med 122 2009 896 903
8. Y.X. Yang, J.D. Lewis, S. Epstein, and D.C. Metz Long-term proton pump inhibitor therapy and risk of hip fracture JAMA 296 2006 2947 2953 (Pubitemid 46021498)
9. P. Vestergaard, L. Rejnmark, and L. Mosekilde Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture Calcif Tissue Int 79 2006 76 83 (Pubitemid 44306164)
10. E. Yu, T. Blackwell, and K. Ensrud Acid-suppressive medications and risk of bone loss and fracture in older adults Calcif Tissue Int 83 2008 251 259
11. L.E. Targownik, L.M. Lix, C.J. Metge, H.J. Prior, S. Leung, and W.D. Leslie Use of proton pump inhibitors and risk of osteoporosis-related fractures CMAJ 179 2008 319 326
12. D.A. Corley, A. Kubo, W. Zhao, and C. Quesenberry Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients Gastroenterology 139 2010 93 101
13. FDA Drug Safety Communication Possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors Rockville, MD: U.S. Food and Drug Administration http://www.fda.gov/drugs/drugsafety/ postmarketdrugsafetyinformationforpatientsandproviders/ucm213206.htm Accessed April 8, 2011
14. S.L. Gray, A.Z. Lacroix, and J. Larson Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative Arch Intern Med 170 2010 765 771
15. J.A. Kaye, and H. Jick Proton pump inhibitor use and risk of hip fractures in patients without major risk factors Pharmacotherapy 28 2008 951 959
16. C. Roux, K. Briot, and L. Gossec Increase in vertebral fracture risk in postmenopausal women using omeprazole Calcif Tissue Int 84 2009 13 19
17. F. De Vries, A.L. Cooper, S.M. Cockle, T.-P. van Staa, and C. Cooper Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates Osteoporosis Int 20 2009 1989 1998
18. S. Pouwels, A. Lalmohamed, and P. Souverein Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study Osteoporosis Int 22 2011 903 910 Epub 2010 Jun 29
19. D. Gagnon, J. Fonda, R. Scranton, and E. Lawler The role of medical comorbidities in the association of proton pump inhibitors PPIs and fractures (meeting abstract) Pharmacoepidemiol Drug Saf 18 2009 S18
20. H.F. Chiu, Y.W. Huang, C.C. Chang, and C.Y. Yang Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study Pharmacoepidemiol Drug Saf 19 2010 1131 1136
21. J.A. Grisso, J.L. Kelsey, and L.A. O'Brien Risk factors for hip fracture in men Hip Fracture Study Group Am J Epidemiol 145 1997 786 793 (Pubitemid 27188515)
22. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188 (Pubitemid 17189972)
23. H.C. van Houwelingen, L.R. Arends, and T. Stijnen Advanced methods in meta-analysis: multivariate approach and meta-regression Stat Med 21 2002 589 624 (Pubitemid 34141379)
24. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560 (Pubitemid 37088507)
25. M. Egger, G. Davey Smith, and D.G. Altman Systematic Reviews in Health Care: Meta-analysis in Context 2nd ed. 2001 BMJ Books London, England
26. M.N. Choudhry, H. Soran, and H.M. Ziglam Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease QJM 101 2008 445 448 (Pubitemid 351791527)
27. C.Q. Pham, R.E. Regal, T.R. Bostwick, and K.S. Knauf Acid suppressive therapy use on an inpatient internal medicine service Ann Pharmacother 40 2006 1261 1266 (Pubitemid 44204954)
28. D.A. Zink, M. Pohlman, M. Barnes, and M.E. Cannon Long-term use of acid suppression started inappropriately during hospitalization Aliment Pharmacol Ther 21 2005 1203 1209 (Pubitemid 40733485)
29. J. Tuukkanen, and H.K. Vaananen Omeprazole, a specific inhibitor of H+-K+-ATPase, inhibits bone resorption in vitro Calcif Tissue Int 38 1986 123 125 (Pubitemid 16113857)
30. I. Kocsis, A. Arato, and H. Bodanszky Short-term omeprazole treatment does not influence biochemical parameters of bone turnover in children Calcif Tissue Int 71 2002 129 132 (Pubitemid 36935477)
31. K. Mizunashi, Y. Furukawa, K. Katano, and K. Abe Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans Calcif Tissue Int 53 1993 21 25 (Pubitemid 23187327)
32. K.E. Hansen, A.N. Jones, and M.J. Lindstrom Do proton pump inhibitors decrease calcium absorption? J Bone Miner Res 25 2010 2510 2519 Epub 2010 Jun 24
33. A. Kirkpantur, B. Altun, M. AriCI, and C. Turgan Proton pump inhibitor omeprazole use is associated with low bone mineral density in maintenance haemodialysis patients Int J Clin Pract 63 2009 261 268
34. L.E. Targownik, L.M. Lix, S. Leung, and W.D. Leslie Proton pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss Gastroenterology 139 2010 896 904 Epub 2009 Nov 18
35. R.R. Recker Calcium absorption and achlorhydria N Engl J Med 313 1985 70 73 (Pubitemid 15068699)
36. H. Hara, T. Suzuki, T. Kasai, Y. Aoyama, and A. Ohta Ingestion of guar-gum hydrolysate partially restores calcium absorption in the large intestine lowered by suppression of gastric acid secretion in rats Br J Nutr 81 1999 315 321 (Pubitemid 29248503)
37. M.B. O'Connell, D.M. Madden, A.M. Murray, R.P. Heaney, and L.J. Kerzner Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial Am J Med 118 2005 778 781 (Pubitemid 40897665)
38. M.J. Wright, R.R. Sullivan, and E. Gaffney-Stomberg Inhibiting gastric acid production does not affect intestinal calcium absorption in young healthy individuals: a randomized, crossover controlled clinical trial J Bone Miner Res 25 2010 2205 2211
39. T.S. Dharmarajan, M.R. Kanagala, P. Murakonda, A.S. Lebelt, and E.P. Norkus Do acid-lowering agents affect vitamin B12 status in older adults? J Am Med Dir Assoc 9 2008 162 167 (Pubitemid 351250797)
40. R.J. Valuck, and J.M. Ruscin A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults J Clin Epidemiol 57 2004 422 428 (Pubitemid 38609284)
41. R.R. McLean, P.F. Jacques, and J. Selhub Homocysteine as a predictive factor for hip fracture in older persons N Engl J Med 350 2004 2042 2049 (Pubitemid 38596555)
42. P. Gerdhem, K.K. Ivaska, and A. Isaksson Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women J Bone Miner Res 22 2007 127 134 (Pubitemid 46032605)
43. M. Epstein, S. McGrath, and F. Law Proton-pump inhibitors and hypomagnesemic hypoparathyroidism N Engl J Med 355 2006 1834 1836
44. G.A. Faulhaber, and T.W. Furlanetto Could magnesium depletion play a role on fracture risk in PPI users? Arch Intern Med 170 2010 1776
45. R. Voelker Proton pump inhibitors linked to fracture risk JAMA 304 2010 2929